David Bailey
Stock Analyst at Morgan Stanley
(3.83)
# 1,954
Out of 5,134 analysts
240
Total ratings
47.6%
Success rate
7.3%
Average return
Main Sectors:
Stocks Rated by David Bailey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: COH Cochlear Limited | Reiterated: Hold | $133.00 | $151.44 | -12.18% | 19 | Nov 16, 2026 | |
| ASX: RMD ResMed Inc. | Reiterated: Hold | n/a | $35.51 | - | 34 | Nov 10, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Reiterated: Sell | $41.90 | $53.60 | -21.83% | 40 | Nov 8, 2026 | |
| ASX: CSL CSL Limited | Reiterated: Buy | $200.00 | $198.51 | +0.75% | 37 | Nov 4, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Reiterated: Buy | $3.70 → $3.00 | $1.61 | +86.05% | 8 | Oct 30, 2026 | |
| RMD ResMed | Reiterated: Hold | $230 → $233 | $238.19 | -2.18% | 18 | Oct 30, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Reiterated: Buy | $23.90 | $13.19 | +81.20% | 18 | Sep 15, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Reiterated: Sell | $20.60 → $20.30 | $19.82 | +2.42% | 21 | Sep 1, 2026 | |
| ASX: ANN Ansell Limited | Reiterated: Hold | $32.70 → $37.90 | $46.19 | -17.95% | 17 | Aug 31, 2026 | |
| NZE: FPH Fisher & Paykel Healthcare Corporation Limited | Reiterated: Buy | n/a | $48.23 | - | 11 | Aug 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $127.50 → $152.50 | $198.48 | n/a | 3 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.50 → $1.35 | $0.59 | n/a | 6 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.05 → $3.55 | $5.10 | n/a | 5 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $13.39 | n/a | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.36 | $5.83 | n/a | 1 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2.75 | $0.87 | n/a | 1 | Jan 21, 2021 |
Cochlear Limited
Nov 16, 2026
Reiterated: Hold
Price Target: $133.00
Current: $151.44
Upside: -12.18%
ResMed Inc.
Nov 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $35.51
Upside: -
Ramsay Health Care Limited
Nov 8, 2026
Reiterated: Sell
Price Target: $41.90
Current: $53.60
Upside: -21.83%
CSL Limited
Nov 4, 2026
Reiterated: Buy
Price Target: $200.00
Current: $198.51
Upside: +0.75%
Integral Diagnostics Limited
Oct 30, 2026
Reiterated: Buy
Price Target: $3.70 → $3.00
Current: $1.61
Upside: +86.05%
ResMed
Oct 30, 2026
Reiterated: Hold
Price Target: $230 → $233
Current: $238.19
Upside: -2.18%
Telix Pharmaceuticals Limited
Sep 15, 2026
Reiterated: Buy
Price Target: $23.90
Current: $13.19
Upside: +81.20%
Sonic Healthcare Limited
Sep 1, 2026
Reiterated: Sell
Price Target: $20.60 → $20.30
Current: $19.82
Upside: +2.42%
Ansell Limited
Aug 31, 2026
Reiterated: Hold
Price Target: $32.70 → $37.90
Current: $46.19
Upside: -17.95%
Fisher & Paykel Healthcare Corporation Limited
Aug 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $48.23
Upside: -
Aug 15, 2024
Reiterated: Buy
Price Target: $127.50 → $152.50
Current: $198.48
Upside: n/a
Feb 28, 2024
Reiterated: Hold
Price Target: $1.50 → $1.35
Current: $0.59
Upside: n/a
Jan 31, 2024
Reiterated: Buy
Price Target: $3.05 → $3.55
Current: $5.10
Upside: n/a
Aug 24, 2021
Reiterated: Hold
Price Target: n/a
Current: $13.39
Upside: n/a
Jan 21, 2021
Reiterated: Hold
Price Target: $0.36
Current: $5.83
Upside: n/a
Jan 21, 2021
Downgraded: Hold
Price Target: $2.75
Current: $0.87
Upside: n/a